New program aims to ease joint pain for breast cancer patients on hormone therapy
NCT ID NCT07500038
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study tested a culturally adapted program to help breast cancer patients manage joint and muscle pain caused by hormone therapy. 289 women on aromatase inhibitors received either the tailored program (health education, monitoring, and nursing guidance) or standard care. Researchers measured changes in joint function and how well the program was adopted in real-world clinics.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Culturally Adapted EBP Program (behavioral intervention: health education, monitoring, nursing guidance)
What this could lead to
If it works, this could provide a practical, culturally sensitive way to help breast cancer patients manage joint pain and stiffness caused by hormone therapy.
What could go wrong
This is a completed implementation study, not a treatment trial. The program may not reduce symptoms significantly more than standard care, and results may not apply to all cultural groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, 200032, China